Carlton Jones

Warwick Warp Ltd. provides software algorithms to enable accurate fingerprint recognition. The firm's products include Warwick Warp LiveScan SDK, Warwick Warp Latent SDK and Warwick Warp AFIS SDK. The company was founded by Roland Wilson, Abhir Hari Bhalerao and Li Wang in 2006 and is headquartered in Stanford-le-Hope, the United Kingdom.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

Part of Mercia Asset Management Plc, Mercia Investments Ltd. provides investment services. The company is based in Henley-in-Arden, UK. Founded in 2014.

Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom.

Enterprise Ventures Group Ltd. provides financing services to small businesses in England and Wales. It offers venture capital, growth capital, and loans to small and medium enterprises. The company was founded in 2001 and is headquartered in Preston, the United Kingdom.

Oxford Genetics Ltd. produces modular DNA plasmids for biological research. Its products include DNA systems, kits, and cell lines. The company was founded by Ryan Cawood and Leonard Seymour on April 28, 2011 and is headquartered in Oxford, the United Kingdom.

PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

The Native Antigen Co. Ltd. develops viral vectors technologies. Its products include bacterial antigens, protozoal, and viral antigens. The company was founded by Nick Roesen and Andrew Maxwell in 2010 and is headquartered in Oxford, the United Kingdom.

Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage.

West Midlands Enterprise Ltd. operates as an alternative investment manager. It provides IT and business consultancy services. The company was founded in 1982 and is headquartered in Solihull, the United Kingdom.

Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK.

The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom.